pembrolizumab
merck
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'nata ', 'colorectal', 'gi ', 'hanna', 'rectal', 'cb-839']
honored to present our phase ii data of glutaminase inhibitor cb-839 +pmab in mcrc with correlatives #wcgic2023 in barcelona- a herculean effort from our gi spore team ! 
GI Med Onc at Vanderbilt @VUMC; wife and mom of 2 daughters